Top Industry Leaders in the Artificial Pancreas Market
Tandem Diabetes Care receives FDA approval for the t slim X2 with Control-IQ technology: August 2023, Tandem secured FDA clearance for its next-generation Artificial Pancreas system, featuring enhanced algorithms and improved user experience.
Medtronic launches MiniMed 780G System in additional countries: September 2023, Medtronic expanded the availability of its MiniMed 780G system to several new countries, including Canada, Australia, and New Zealand.
Beta Bionics receives Breakthrough Device designation for iLet Bionic Pancreas: October 2023, Beta Bionics earned Breakthrough Device designation from the FDA for its iLet Bionic Pancreas, targeting adolescents and adults with type 1 diabetes.
List of Artificial Pancreas Key Companies in the Market
- Medtronic
- Johnson & Johnson
- Beta Bionics
- Bigfoot Biomedical
- Admetsys (pipeline product analysis)
- Animas Corporation
- Defymed
- dexcom
- Insulet
- medtech
- Medtronic
- Semma Therapeutics
- Tandem Diabetes Care
- TypeZero Technologies